Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,657 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers.
Dutta S, Bhattacharya S, Harris H, Islam R, Bodas S, Polavaram N, Mishra J, Das D, Seshacharyulu P, Kalluchi A, Pal A, Kohli M, Lele S, Muders M, Batra S, Ghosh P, Datta K, Rowley M. Dutta S, et al. Among authors: ghosh p. Res Sq [Preprint]. 2023 Dec 11:rs.3.rs-3464475. doi: 10.21203/rs.3.rs-3464475/v1. Res Sq. 2023. Update in: Cell Death Dis. 2024 Aug 25;15(8):617. doi: 10.1038/s41419-024-06916-y PMID: 38168280 Free PMC article. Updated. Preprint.
Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer.
Dutta S, Polavaram NS, Islam R, Bhattacharya S, Bodas S, Mayr T, Roy S, Albala SAY, Toma MI, Darehshouri A, Borkowetz A, Conrad S, Fuessel S, Wirth M, Baretton GB, Hofbauer LC, Ghosh P, Pienta KJ, Klinkebiel DL, Batra SK, Muders MH, Datta K. Dutta S, et al. Among authors: ghosh p. Oncogene. 2022 Jul;41(30):3747-3760. doi: 10.1038/s41388-022-02382-y. Epub 2022 Jun 27. Oncogene. 2022. PMID: 35754042 Free PMC article.
Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers.
Bhattacharya S, Harris HL, Islam R, Bodas S, Polavaram N, Mishra J, Das D, Seshacharyulu P, Kalluchi A, Pal A, Kohli M, Lele SM, Muders M, Batra SK, Ghosh PM, Datta K, Rowley MJ, Dutta S. Bhattacharya S, et al. Among authors: ghosh pm. Cell Death Dis. 2024 Aug 25;15(8):617. doi: 10.1038/s41419-024-06916-y. Cell Death Dis. 2024. PMID: 39183332 Free PMC article.
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes.
Ning S, Zhao J, Lombard AP, D'Abronzo LS, Leslie AR, Sharifi M, Lou W, Liu C, Yang JC, Evans CP, Corey E, Chen HW, Yu A, Ghosh PM, Gao AC. Ning S, et al. Among authors: ghosh pm. Commun Med (Lond). 2022 Sep 21;2:118. doi: 10.1038/s43856-022-00182-9. eCollection 2022. Commun Med (Lond). 2022. PMID: 36159187 Free PMC article.
Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
Chen L, Siddiqui S, Bose S, Mooso B, Asuncion A, Bedolla RG, Vinall R, Tepper CG, Gandour-Edwards R, Shi X, Lu XH, Siddiqui J, Chinnaiyan AM, Mehra R, Devere White RW, Carraway KL 3rd, Ghosh PM. Chen L, et al. Cancer Res. 2010 Jul 15;70(14):5994-6003. doi: 10.1158/0008-5472.CAN-09-4440. Epub 2010 Jun 29. Cancer Res. 2010. PMID: 20587519 Free PMC article.
3,657 results